Spots Global Cancer Trial Database for epidoxorubicin and cisplatin and lipiodol
Every month we try and update this database with for epidoxorubicin and cisplatin and lipiodol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | NCT03192644 | Hepatocellular ... | TAI TACE epidoxorubicin ... mFOLFOX6 (oxali... | 18 Years - 75 Years | Sun Yat-sen University | |
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | NCT03192644 | Hepatocellular ... | TAI TACE epidoxorubicin ... mFOLFOX6 (oxali... | 18 Years - 75 Years | Sun Yat-sen University |